Juan LI, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC (NCT05157542) | Juan LI, MD | 2021-06-10 |
Track Juan LI, MD automatically
Every clearance here is in the API, with alerts when new ones post.